SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-001988
Filing Date
2024-02-28
Accepted
2024-02-28 16:01:51
Documents
93
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vygr-20231231x10k.htm   iXBRL 10-K 3409583
2 EX-10.43 vygr-20231231xex10d43.htm EX-10.43 671698
3 EX-10.44 vygr-20231231xex10d44.htm EX-10.44 341367
4 EX-10.45 vygr-20231231xex10d45.htm EX-10.45 146095
5 EX-10.46 vygr-20231231xex10d46.htm EX-10.46 23595
6 EX-10.47 vygr-20231231xex10d47.htm EX-10.47 41028
7 EX-21.1 vygr-20231231xex21d1.htm EX-21.1 4959
8 EX-23.1 vygr-20231231xex23d1.htm EX-23.1 6871
9 EX-31.1 vygr-20231231xex31d1.htm EX-31.1 10387
10 EX-31.2 vygr-20231231xex31d2.htm EX-31.2 10304
11 EX-32.1 vygr-20231231xex32d1.htm EX-32.1 12849
12 EX-97.1 vygr-20231231xex97d1.htm EX-97.1 21987
13 GRAPHIC vygr-20231231x10k006.jpg GRAPHIC 78213
  Complete submission text file 0001558370-24-001988.txt   13868796

Data Files

Seq Description Document Type Size
14 EX-101.SCH vygr-20231231.xsd EX-101.SCH 69980
15 EX-101.CAL vygr-20231231_cal.xml EX-101.CAL 68293
16 EX-101.DEF vygr-20231231_def.xml EX-101.DEF 334288
17 EX-101.LAB vygr-20231231_lab.xml EX-101.LAB 595087
18 EX-101.PRE vygr-20231231_pre.xml EX-101.PRE 525486
95 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20231231x10k_htm.xml XML 2190221
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37625 | Film No.: 24695052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)